Announced
Completed
Synopsis
Obvious Ventures, True Ventures and Kittyhawk Ventures led a $60m round in MycoMedica, a company focused on developing and delivering fungi-based therapeutic drugs. “This is an exciting step on a lifelong journey to expand knowledge and unlock the healing potential of fungi, and we are grateful for the support from this outstanding group of funders who share our vision and values to help people live healthier, better lives,” Paul Stamets, MycoMedica CEO and Founder.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.